Impact of web application support versus standard management on adherence with adjuvant hormone therapy in patients treated for breast cancer: the WEBAPPAC study

[1] Anderson E(2002)The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis Breast Cancer Res 4 197-201

[2] Davies C(2011)Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials Lancet 378 771-84

[3] Godwin J(2019)Efficacy of extended aromatase inhibitors for hormone-receptor-positive breast cancer: a literature-based meta-analysis of randomized trials Breast 46 19-24

[4] Gray R(2014)Extended adjuvant tamoxifen for early breast cancer: a meta-analysis PLoS ONE 9 e88238-40

[5] Clarke M(2013)Five or more years of adjuvant endocrine therapy in breast cancer: a meta-analysis of published randomised trials Breast Cancer Res Treat 140 233-34

[6] Cutter D(2007)Aromatase inhibitor-associated arthralgia syndrome Breast 16 223-50

[7] Darby S(2011)Prevalence and associated factors of sexual problems after early-stage breast cancer treatment: results of a french exploratory survey Psycho‐Oncology 20 841-7

[8] McGale P(2013)Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors BMC Cancer 13 401-8

[9] Pan HC(2010)Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients J Clin Oncol 28 4120-8

[10] Taylor C(2022)Efficacy and safety of app-based remote warfarin management during COVID-19-related lockdown: a retrospective cohort study J Thromb Thrombolysis 54 20-76

[1] Anderson E(2002)The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis Breast Cancer Res 4 197-201

[2] Davies C(2011)Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials Lancet 378 771-84

[3] Godwin J(2019)Efficacy of extended aromatase inhibitors for hormone-receptor-positive breast cancer: a literature-based meta-analysis of randomized trials Breast 46 19-24

[4] Gray R(2014)Extended adjuvant tamoxifen for early breast cancer: a meta-analysis PLoS ONE 9 e88238-40

[5] Clarke M(2013)Five or more years of adjuvant endocrine therapy in breast cancer: a meta-analysis of published randomised trials Breast Cancer Res Treat 140 233-34

[6] Cutter D(2007)Aromatase inhibitor-associated arthralgia syndrome Breast 16 223-50

[7] Darby S(2011)Prevalence and associated factors of sexual problems after early-stage breast cancer treatment: results of a french exploratory survey Psycho‐Oncology 20 841-7

[8] McGale P(2013)Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors BMC Cancer 13 401-8

[9] Pan HC(2010)Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients J Clin Oncol 28 4120-8

[10] Taylor C(2022)Efficacy and safety of app-based remote warfarin management during COVID-19-related lockdown: a retrospective cohort study J Thromb Thrombolysis 54 20-76